ArticleACS medicinal chemistry letters2026

Structure- and Ligand-Based Discovery of Novel Non-Arginine-Based DDAH1 Inhibitors with Anti-Triple-Negative Breast Cancer Activity.

Anthony J Doman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.